Trividia Health Initiates Recall of TRUE METRIX Blood Glucose Meters Due to Display Defects

What's Happening?

Trividia Health, Inc. has announced a voluntary recall of a limited number of TRUE METRIX Self-Monitoring Blood Glucose Meters. The recall affects 601 meters from lot number KD0746, manufactured on September 4, 2025, and distributed between September 8 and September 16, 2025. The recall is due to potential defects in the LCD displays, which may show partial or missing numerical segments or characters, potentially leading to misinterpretation of test results. This could delay treatment for users with low glucose levels. No injuries have been reported. Consumers can verify if their product is affected by contacting Trividia Health's Customer Care Department or checking the lot number on the product's box.

Why It's Important?

The recall is significant as it underscores the importance of accuracy in medical devices, particularly those used for monitoring critical health conditions like diabetes. Defective glucose meters could lead to incorrect readings, impacting treatment decisions and potentially endangering patients' health. The recall, conducted in coordination with the FDA, highlights the regulatory oversight in ensuring patient safety. It also reflects the company's commitment to addressing product issues promptly to maintain trust with consumers and healthcare providers.

What's Next?

Trividia Health is notifying its customers, including pharmacies and distributors, about the recall. Consumers with affected products will receive assistance for returns and replacements. The company will continue to work with the FDA to resolve the issue swiftly. This situation may prompt increased scrutiny on the manufacturing processes of medical devices to prevent similar occurrences in the future.